E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/18/2010 in the Prospect News Distressed Debt Daily.

Quigley net loss grows to $522,068 in September; sales remain $50,001

By Caroline Salls

Pittsburgh, Oct. 18 - Quigley Co. Inc. reported a $522,068 net loss for September on $50,001 of revenues, according to its monthly operating report filed Friday with the U.S. Bankruptcy Court for the Southern District of New York.

In comparison, the company posted a $411,999 net loss for August, also on $50,001 of revenues.

Cash and cash equivalents at Sept. 30 were $149,943, down from $181,366 at the end of August.

Quigley, a unit of Pfizer Inc., filed for bankruptcy on Sept. 3, 2004. Its Chapter 11 case number is 04-15739.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.